Thermo Fisher Scientific Inc. (ETR: TN8)
Germany
· Delayed Price · Currency is EUR 497.00
-8.80 (-1.74%)
Dec 19, 2024, 5:35 PM CET
Thermo Fisher Scientific Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 28, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 6,135 | 5,995 | 6,950 | 7,725 | 6,375 | 3,696 | Upgrade
|
| Depreciation & Amortization | 3,200 | 3,406 | 3,381 | 2,592 | 2,325 | 2,277 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | -482 | Upgrade
|
| Asset Writedown & Restructuring Costs | 5 | - | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 283 | 278 | 307 | 230 | 196 | 181 | Upgrade
|
| Other Operating Activities | -1,273 | -736 | -435 | 313 | -212 | -34 | Upgrade
|
| Change in Accounts Receivable | 209 | 209 | -784 | 17 | -1,302 | -225 | Upgrade
|
| Change in Inventory | 598 | 598 | -825 | -1,065 | -508 | -458 | Upgrade
|
| Change in Accounts Payable | -500 | -500 | 648 | 479 | 59 | 266 | Upgrade
|
| Change in Other Net Operating Assets | 443 | -844 | -88 | -979 | 1,356 | -248 | Upgrade
|
| Operating Cash Flow | 9,100 | 8,406 | 9,154 | 9,312 | 8,289 | 4,973 | Upgrade
|
| Operating Cash Flow Growth | 11.38% | -8.17% | -1.70% | 12.34% | 66.68% | 9.47% | Upgrade
|
| Capital Expenditures | -1,325 | -1,479 | -2,243 | -2,523 | -1,474 | -926 | Upgrade
|
| Sale of Property, Plant & Equipment | 51 | 87 | 24 | 20 | 8 | 36 | Upgrade
|
| Cash Acquisitions | -3,132 | -3,660 | -39 | -19,395 | -38 | -1,843 | Upgrade
|
| Divestitures | - | - | - | - | - | 1,128 | Upgrade
|
| Investment in Securities | -1,865 | - | - | - | - | - | Upgrade
|
| Other Investing Activities | 34 | -90 | 99 | -34 | -6 | 118 | Upgrade
|
| Investing Cash Flow | -6,237 | -5,142 | -2,159 | -21,932 | -1,510 | -1,487 | Upgrade
|
| Short-Term Debt Issued | - | 1,620 | 1,526 | 2,512 | 383 | 2,781 | Upgrade
|
| Long-Term Debt Issued | - | 5,942 | 3,193 | 18,137 | 3,464 | 5,638 | Upgrade
|
| Total Debt Issued | 3,680 | 7,562 | 4,719 | 20,649 | 3,847 | 8,419 | Upgrade
|
| Short-Term Debt Repaid | - | -1,935 | -3,690 | - | -387 | -3,464 | Upgrade
|
| Long-Term Debt Repaid | - | -5,782 | -375 | -11,738 | -710 | -6,355 | Upgrade
|
| Total Debt Repaid | -4,889 | -7,717 | -4,065 | -11,738 | -1,097 | -9,819 | Upgrade
|
| Net Debt Issued (Repaid) | -1,209 | -155 | 654 | 8,911 | 2,750 | -1,400 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 153 | Upgrade
|
| Repurchase of Common Stock | -3,000 | -3,000 | -3,000 | -2,000 | -1,500 | -1,500 | Upgrade
|
| Common Dividends Paid | -570 | -523 | -455 | -395 | -337 | -297 | Upgrade
|
| Other Financing Activities | 225 | 56 | -9 | 65 | 46 | -74 | Upgrade
|
| Financing Cash Flow | -4,554 | -3,622 | -2,810 | 6,581 | 959 | -3,118 | Upgrade
|
| Foreign Exchange Rate Adjustments | 192 | -82 | -139 | 194 | 176 | -63 | Upgrade
|
| Net Cash Flow | -1,498 | -440 | 4,046 | -5,845 | 7,914 | 305 | Upgrade
|
| Free Cash Flow | 7,775 | 6,927 | 6,911 | 6,789 | 6,815 | 4,047 | Upgrade
|
| Free Cash Flow Growth | 18.77% | 0.23% | 1.80% | -0.38% | 68.40% | 6.92% | Upgrade
|
| Free Cash Flow Margin | 18.35% | 16.16% | 15.39% | 17.31% | 21.15% | 15.84% | Upgrade
|
| Free Cash Flow Per Share | 20.23 | 17.85 | 17.54 | 17.10 | 17.08 | 10.04 | Upgrade
|
| Cash Interest Paid | 1,385 | 1,385 | 667 | 555 | 471 | 790 | Upgrade
|
| Cash Income Tax Paid | 1,742 | 1,482 | 1,234 | 2,182 | 1,324 | 896 | Upgrade
|
| Levered Free Cash Flow | 6,782 | 5,141 | 5,798 | 5,584 | 5,618 | 3,232 | Upgrade
|
| Unlevered Free Cash Flow | 7,697 | 6,000 | 6,252 | 5,919 | 5,964 | 3,654 | Upgrade
|
| Change in Net Working Capital | -925 | 826 | 543 | 863 | - | 494 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.